Total Payments
$61,978
2024 Payments
$1,818
Companies
51
Transactions
527
Medicare Patients
1,002
Medicare Billing
$162,604
Payment Breakdown by Category
Other$25,080 (40.5%)
Consulting$20,606 (33.2%)
Food & Beverage$9,225 (14.9%)
Travel$6,875 (11.1%)
Education$191.96 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,080 | 6 | 40.5% |
| Consulting Fee | $20,606 | 7 | 33.2% |
| Food and Beverage | $9,225 | 467 | 14.9% |
| Travel and Lodging | $6,875 | 44 | 11.1% |
| Education | $191.96 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $47,634 | 82 | $0 (2024) |
| Gilead Sciences, Inc. | $3,756 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,825 | 21 | $0 (2024) |
| Exelixis Inc. | $1,233 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $662.80 | 44 | $0 (2024) |
| Genentech USA, Inc. | $559.91 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $516.03 | 30 | $0 (2024) |
| GENZYME CORPORATION | $510.09 | 29 | $0 (2024) |
| Daiichi Sankyo Inc. | $432.16 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $368.47 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,818 | 97 | GENZYME CORPORATION ($198.81) |
| 2023 | $5,019 | 84 | Regeneron Healthcare Solutions, Inc. ($2,633) |
| 2022 | $4,434 | 56 | Gilead Sciences, Inc. ($3,547) |
| 2021 | $348.23 | 23 | Seagen Inc. ($80.29) |
| 2020 | $1,014 | 34 | Bayer HealthCare Pharmaceuticals Inc. ($580.08) |
| 2019 | $950.09 | 64 | Genentech USA, Inc. ($151.50) |
| 2018 | $31,355 | 98 | Bayer HealthCare Pharmaceuticals Inc. ($30,811) |
| 2017 | $17,040 | 71 | Bayer HealthCare Pharmaceuticals Inc. ($16,127) |
All Payment Transactions
527 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 12/17/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Hematology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Oncology | ||||||
| 12/06/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.45 | General |
| 11/21/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: BioOncology | ||||||
| 11/19/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology | ||||||
| 11/08/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/24/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $13.96 | General |
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Hematology/Oncology | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 220 | 394 | $87,277 | $31,996 |
| 2022 | 5 | 203 | 488 | $98,507 | $36,205 |
| 2021 | 5 | 317 | 528 | $110,139 | $49,428 |
| 2020 | 7 | 262 | 485 | $99,704 | $44,975 |
Total Patients
1,002
Total Services
1,895
Medicare Billing
$162,604
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 96 | 207 | $39,123 | $13,832 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 42 | 81 | $21,627 | $9,087 | 42.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 41 | $7,134 | $2,773 | 38.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $8,784 | $2,617 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $6,919 | $2,163 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 30 | $3,690 | $1,524 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 94 | 306 | $57,834 | $21,041 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 59 | $15,753 | $6,498 | 41.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 56 | $9,744 | $3,249 | 33.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $9,272 | $3,077 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 48 | $5,904 | $2,340 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 140 | $26,460 | $13,313 | 50.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 138 | $25,953 | $11,693 | 45.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 36 | $17,568 | $6,025 | 34.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 40 | $10,680 | $6,017 | 56.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 68 | $11,832 | $4,196 | 35.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 20 | 32 | $8,544 | $3,565 | 41.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 40 | $4,920 | $2,677 | 54.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 34 | $4,182 | $1,943 | 46.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 237 | $44,793 | $21,430 | 47.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 67 | $17,889 | $8,123 | 45.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 70 | $8,610 | $4,464 | 51.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 32 | 64 | $11,136 | $4,068 | 36.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 19 | $9,272 | $3,387 | 36.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,992 | $2,404 | 48.1% |
About Dr. Gerardo Capo, MD
Dr. Gerardo Capo, MD is a Specialist healthcare provider based in Elizabeth, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225049505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerardo Capo, MD has received a total of $61,978 in payments from pharmaceutical and medical device companies, with $1,818 received in 2024. These payments were reported across 527 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,080).
As a Medicare-enrolled provider, Capo has provided services to 1,002 Medicare beneficiaries, totaling 1,895 services with total Medicare billing of $162,604. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology, Medical Oncology
- Location Elizabeth, NJ
- Active Since 08/11/2006
- Last Updated 05/21/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1225049505
Products in Payments
- Stivarga (Drug) $46,922
- LIBTAYO (Biological) $2,825
- CABOMETYX (Drug) $1,154
- OPDIVO (Biological) $599.34
- KEYTRUDA (Biological) $428.69
- SARCLISA (Biological) $361.79
- INJECTAFER (Drug) $280.93
- REBLOZYL (Biological) $187.43
- IBRANCE (Drug) $166.35
- Avastin (Biological) $164.24
- Lenvima (Drug) $151.06
- TUKYSA (Drug) $141.51
- JAKAFI (Drug) $139.42
- LYNPARZA (Drug) $135.28
- VERZENIO (Drug) $134.68
- KISQALI (Drug) $128.70
- IMBRUVICA (Drug) $120.39
- PROVENGE (Drug) $116.61
- DARZALEX (Biological) $104.38
- LONSURF (Drug) $101.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Elizabeth
Vincent Salerno, Md, MD
Specialist — Payments: $6,919
Specialist $6,919
Julius Salamera, M.d, M.D
Specialist — Payments: $2,611
Specialist $2,611
Dr. Kamran Khazai, Md, MD
Specialist — Payments: $1,075
Specialist $1,075
Dr. Arun Naik, Md, MD
Specialist — Payments: $676.56
Specialist $676.56
Dr. Eddy Joseph, Md, MD
Specialist — Payments: $446.29
Specialist $446.29
Johanna Gonzalez Mejia, M.d, M.D
Specialist — Payments: $295.97
Specialist $295.97